Business Context and Reporting Period
This Form 6-K/A filing by GlaxoSmithKline plc covers the period ending February 2015. The document serves as a notification of transactions involving Persons Discharging Managerial Responsibility (PDMR) under the GlaxoSmithKline Share Value Plan (SVP). It details share sales and ADS withholdings executed on February 18, 2015, to satisfy tax liabilities arising from the vesting of awards granted in 2012.
Key Financial Metrics
The filing does not provide consolidated financial statements, revenue, profit, cash flow, margins, debt, or liquidity metrics. The only financial data disclosed relates to specific transaction prices for share disposals:
- Ordinary Share Price: £15.353625 per share.
- American Depositary Share (ADS) Price: $47.94 per ADS.
Material Changes
The filing reports specific changes in the shareholdings of three PDMRs due to tax-related sales:
- Mr. R. Connor: Sold 8,423 Ordinary Shares.
- Mrs. V. Whyte: Sold 6,143 Ordinary Shares.
- Mr. N. Hirons: Had 1,891 ADSs withheld.
No material changes to the company's operational or financial status are reported in this document.
Guidance, Outlook, and Risks
This filing contains no management commentary, forward-looking guidance, outlook, risk factors, or discussion of contingencies. It is strictly a regulatory disclosure of insider trading activity compliant with Disclosure and Transparency Rule 3.1.4R(1)(a).
Investor Verification Checklist
- Verify the total number of shares sold by PDMRs to ensure compliance with insider trading policies.
- Confirm the share price (£15.353625) and ADS price ($47.94) align with market prices on February 18, 2015.
- Note that this filing does not contain financial performance data; refer to the company's Form 20-F or quarterly reports for revenue and earnings.